Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
UTI Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesEQ - SUN PHARMACEUTICALS INDUSTRIES9.6072661016105.3858
Domestic EquitiesEQ - AJANTA PHARMA LTD.5.484125000060.1575
Domestic EquitiesEQ - CIPLA LTD.5.481740000060.1320
Domestic EquitiesEQ - LUPIN LTD.4.704427000051.6051
Domestic EquitiesEQ - PROCTOR & GAMBLE HEALTH LTD3.98596932043.7236
Domestic EquitiesEQ - GLENMARK PHARMACEUTICALS LTD.3.738221000041.0067
Domestic EquitiesEQ - DR REDDYS LABORATORIES LTD.3.737133500040.9940
Domestic EquitiesEQ - GLAND PHARMA LTD.3.618419929739.6920
Domestic EquitiesEQ - APOLLO HOSPITALS ENTERPRISE LT3.57975300039.2677
Domestic EquitiesEQ - ALKEM LABORATORIES LTD3.56087200039.0600
Domestic EquitiesEQ - FORTIS HEALTHCARE LTD.3.536340000038.7920
Domestic EquitiesEQ- JUPITER LIFE LINE HOSPITALS LTD3.146922697234.5202
Domestic EquitiesEQ - COHANCE LIFESCIENCES LIMITED2.886036011431.6576
Domestic EquitiesEQ - DIVIS LABORATORIES LTD.2.59335000028.4475
Domestic EquitiesEQ - ERIS LIFESCIENCES LTD2.590217915828.4127
Domestic EquitiesEQ - AUROBINDO PHARMA LTD.2.470325000027.0975
Domestic EquitiesEQ - MAX HEALTHCARE INSTITUTE LTD2.438824000026.7528
Domestic EquitiesEQ - CAPLIN POINT LABORATORIES LTD2.345013083725.7239
Domestic EquitiesEQ - KRISHNA INSTITUTE OF MEDI SCIE2.253935313224.7245
Domestic EquitiesEQ - IPCA LABORATORIES LTD.1.918315715621.0432
Domestic EquitiesEQ - SAI LIFE SCIENCES LTD1.801722962319.7637
Domestic EquitiesEQ - METROPOLIS HEALTHCARE LTD1.79539672619.6934
Domestic EquitiesEQ- GLOBAL HEALTH LTD.1.772414796619.4427
Domestic EquitiesEQ - PFIZER LIMITED1.77223860219.4400
Domestic EquitiesEQ - ASTER DM HEALTHCARE LTD1.743230500019.1220
Domestic EquitiesEQ - SEQUENT SCIENTIFIC LTD1.479487114516.2286
Domestic EquitiesEQ - ANTHEM BIOSCIENCES LTD1.460921052216.0249
Domestic EquitiesEQ - WINDLAS BIOTEC LTD1.325416050714.5395
Domestic EquitiesEQ - MARKSANS PHARMA LTD.1.135975500012.4605
Domestic EquitiesEQ - VIJAYA DIAGNOSTIC CENTRE LTD1.093912000012.0000
Domestic EquitiesEQ - BIOCON LTD.1.088035000011.9350
Domestic EquitiesEQ - ACUTAAS CHEMICALS LIMITED1.07198922411.7579
Domestic EquitiesEQ - SANOFI CONSUMER HEALTHCARE INDIA LTD1.03042394511.3032
Domestic EquitiesEQ - SYNGENE INTERNATIONAL LTD.1.022018000011.2113
Domestic EquitiesEQ - TORRENT PHARMACEUTICALS LTD.0.98543000010.8096
Domestic EquitiesEQ - RAINBOW CHILDRENS MEDICARE LTD0.97227865010.6649
Domestic EquitiesEQ - ALEMBIC PHARMACEUTICALS0.89851093509.8563
Domestic EquitiesEQ - JUBILANT PHARMOVA LIMITED0.8824896759.6795
Domestic EquitiesEQ - EMCURE PHARMACEUTICALS LTD0.8751750009.5993
Domestic EquitiesEQ - ORCHID PHARMA LTD.0.64001000007.0200
Domestic EquitiesEQ - LAXMI DENTAL LIMITED0.45251526214.9632
Total 98.9755 1085.7118
Cash & Cash Equivalents and Net AssetsNET CURRENT ASSETS1.0154 11.1386
Total 1.0154 11.1386
Deposits (Placed as Margin)CLEARING CORPORATION OF INDIA LTD. STD - MARGIN0.0091 0.1000
Total 0.0091 0.1000
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.